Dr. David Reardon is a professor of medicine at Harvard Medical School and currently serves as the director of Dana-Farber Cancer Institute’s Center for Neuro-Oncology. He previously served as the associate deputy director of the Duke University Medical Center’s Preston Robert Tisch Brain Tumor Center for 11 years. He is an active researcher with special interests in the design and implementation of clinical trials for individuals with brain and spinal tumors, focusing particularly on immunotherapeutics. He has also led investigations of molecular-targeting agents, anti-angiogenic reagents, cytotoxins, and other biologically-based therapies. Dr. Reardon has published over 290 peer-reviewed manuscripts. He has received the R. Wayne Rundles Award for Excellence in Cancer Research as well as the Award for Excellence in Adult Clinical Research by the Society for Neuro-Oncology in 2015 and 2016. He served as the tenth president of the Society for Neuro-Oncology from 2013-2015.